Arrhythmia Research Technology Inc (HRT) 7.71 $HRT
Arrhythmia Research Technology, Inc. Appoints Derek T. Welch as Chief Financial Officer
GlobeNewswire - Mon Jan 12, 3:11PM CST
Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the "Company"
, operating through its wholly-owned subsidiary, Micron Products, Inc., a manufacturer of highly engineered, complex components, devices and equipment for OEM customers announced today the appointment of Mr. Derek T. Welch as the Company's Chief Financial Officer effective January 1, 2015.
HRT: 7.71 (+0.06)
Micron Products, Inc. Announces Exclusive Agreement With New Era Orthopaedics, LLC
GlobeNewswire - Tue Dec 23, 11:19AM CST
Micron Products, Inc. ("Micron" or the "Company" , a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today that the Company has entered into a five-year, exclusive manufacturing agreement with New Era Orthopaedics, LLC ("NEO" for its next generation, comprehensive offering of total knee, hip and spine systems.
HRT: 7.71 (+0.06)
Arrhythmia Research Tech (HRT) Upgraded From Sell to Hold
at The Street - Thu Dec 04, 5:50AM CST
Arrhythmia Research Tech (HRT) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
HRT: 7.71 (+0.06)
Arrhythmia Research reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 6:53AM CST
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Achieved 27.9% Revenue Growth and $0.05 Earnings Per Share for Third Quarter 2014
GlobeNewswire - Wed Nov 12, 5:55AM CST
-- Net sales in the quarter were $6.0 million, up $1.3 million, driven by growth in all product lines
HRT: 7.71 (+0.06)
Micron Products, Inc. Appoints Albert McGrath as Vice President of Operations
GlobeNewswire - Thu Oct 30, 12:30PM CDT
Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today it has appointed medical device industry professional Albert (Bert) McGrath as the Company's Vice President of Operations, effective November 1. Mr. McGrath brings extensive operations experience to Micron, including a long career in orthopedic implant and medical device manufacturing. He has led operations for leading medical device manufacturers, including ConforMIS, Inc., Tornier, Inc., and Smith and Nephew, Inc.
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Reports 28.1% Revenue Growth; Delivered $0.09 in Earnings per Share for Second Quarter 2014
GlobeNewswire - Thu Aug 07, 3:44PM CDT
-- Net sales increased 28.1% over second quarter 2013 to $6.3 million; Net sales were up 16.7% year to date
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Announces Date of Annual Meeting of Shareholders
Marketwire - Fri Feb 14, 8:22AM CST
Arrhythmia Research Technology, Inc. (NYSE MKT: HRT) today announced that its annual meeting of shareholders will be held on Thursday, May 22, 2014 at 10:00 a.m. at the Double Tree by Hilton Hotel, 99 Erdman Way, Leominster, Massachusetts for shareholders of record as of April 2, 2014.
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Appoints Derek T. Welch as Chief Financial Officer
GlobeNewswire - Mon Jan 12, 3:11PM CST
Arrhythmia Research Technology, Inc. (NYSE MKT:HRT) (the "Company"
, operating through its wholly-owned subsidiary, Micron Products, Inc., a manufacturer of highly engineered, complex components, devices and equipment for OEM customers announced today the appointment of Mr. Derek T. Welch as the Company's Chief Financial Officer effective January 1, 2015. HRT: 7.71 (+0.06)
Micron Products, Inc. Announces Exclusive Agreement With New Era Orthopaedics, LLC
GlobeNewswire - Tue Dec 23, 11:19AM CST
Micron Products, Inc. ("Micron" or the "Company"
, a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today that the Company has entered into a five-year, exclusive manufacturing agreement with New Era Orthopaedics, LLC ("NEO" for its next generation, comprehensive offering of total knee, hip and spine systems. HRT: 7.71 (+0.06)
Arrhythmia Research Tech (HRT) Upgraded From Sell to Hold
at The Street - Thu Dec 04, 5:50AM CST
Arrhythmia Research Tech (HRT) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
HRT: 7.71 (+0.06)
Arrhythmia Research reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 6:53AM CST
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Achieved 27.9% Revenue Growth and $0.05 Earnings Per Share for Third Quarter 2014
GlobeNewswire - Wed Nov 12, 5:55AM CST
-- Net sales in the quarter were $6.0 million, up $1.3 million, driven by growth in all product lines
HRT: 7.71 (+0.06)
Micron Products, Inc. Appoints Albert McGrath as Vice President of Operations
GlobeNewswire - Thu Oct 30, 12:30PM CDT
Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today it has appointed medical device industry professional Albert (Bert) McGrath as the Company's Vice President of Operations, effective November 1. Mr. McGrath brings extensive operations experience to Micron, including a long career in orthopedic implant and medical device manufacturing. He has led operations for leading medical device manufacturers, including ConforMIS, Inc., Tornier, Inc., and Smith and Nephew, Inc.
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Reports 28.1% Revenue Growth; Delivered $0.09 in Earnings per Share for Second Quarter 2014
GlobeNewswire - Thu Aug 07, 3:44PM CDT
-- Net sales increased 28.1% over second quarter 2013 to $6.3 million; Net sales were up 16.7% year to date
HRT: 7.71 (+0.06)
Arrhythmia Research Technology, Inc. Announces Date of Annual Meeting of Shareholders
Marketwire - Fri Feb 14, 8:22AM CST
Arrhythmia Research Technology, Inc. (NYSE MKT: HRT) today announced that its annual meeting of shareholders will be held on Thursday, May 22, 2014 at 10:00 a.m. at the Double Tree by Hilton Hotel, 99 Erdman Way, Leominster, Massachusetts for shareholders of record as of April 2, 2014.
HRT: 7.71 (+0.06)
